SHUA11014U Translational Pharmacology - From Concept to Medical Drug and from Concept to Biotech Company
Volume 2016/2017
Education
MSc Programme in Human Biology - elective
Content
Translational pharmacology describes the process from basic pharmacological research to an approved medical drug, i.e. from idea to a pharmaceutical that can be used in therapy, including a review of the basis for setting up, funding and developing a biotech company based on drug discovery and development.
Learning Outcome
At the end of the course, students should be able to:
Discuss, analyze and evaluate:
- Drug targets – concept, discovery and validation
- The identification of hits and leads: structure-based drug discovery
- Optimising the medicinal chemistry and testing the properties of target molecules and of ADME properties in vitro and in vivo
- Animal models for testing the effectiveness of medical drugs, PK, and the like
- The development and clinical trials of pharmaceuticals
- Setting up and funding biotech companies based on drug discovery and development – phases in the biotech company lifecycle
- Analysis and comparisons of domestic and international biotech companies based on drug discovery and development
Recommended Academic Qualifications
A completed Bachelor
degree within the Biomedical and Natural Sciences
Teaching and learning methods
Lectures, assignments and
case presentations in plenum
Workload
- Category
- Hours
- Exam
- 1
- Lectures
- 35
- Practical exercises
- 16
- Preparation
- 84
- Total
- 136
Sign up
Self Service at
KUnet
Exam (Course certificate)
- Credit
- 5 ECTS
- Type of assessment
- Oral examination, 1 hourCourse participationOral presentation and discussion in course plenum of a case-story in drug-discovery or biotech company establisment and management.
- Aid
- Only certain aids allowed
All, except for external communication devices
- Marking scale
- passed/not passed
- Censorship form
- No external censorship
More than one internal examiner
- Exam period
Week 44 (Friday)
Criteria for exam assesment
To achieve the grade Passed, the student must adequately be able to:
Discuss, analyze and evaluate:
- Drug targets – concept, discovery and validation
- The identification of hits and leads: structure-based drug discovery
- Optimising the medicinal chemistry and testing the properties of target molecules and of ADME properties in vitro and in vivo
- Animal models for testing the effectiveness of medical drugs, PK, and the like
- The development and clinical trials of pharmaceuticals
- Setting up and funding biotech companies based on drug discovery and development – phases in the biotech company lifecycle
- Analysis and comparisons of domestic and international biotech companies based on drug discovery and development
Course information
- Language
- English
- Course code
- SHUA11014U
- Credit
- 5 ECTS
- Level
- Full Degree Master
- Duration
- 2 weeks
- Placement
- Block 1
Weeks 43-44
- Schedule
- See Syllabus
- Course capacity
- 30 participants
- Continuing and further education
- Study board
- Study board of Human Biology
Contracting department
- Department of Neuroscience and Pharmacology
Course responsibles
- Birgitte Holst (5-6a716e75764275777066306d7730666d)
- Siv Annegrethe Hjorth (9-756b786a6c7174766a4275777066306d7730666d)
Saved on the
27-10-2016